KLRK1 and cancer: NKG2D expressing CARs have shown positive results when it comes to effectiveness against most cancer types, such as breast cancer, as well as lung, colon, ovarian carcinoma and glioma, neuroblastoma, leukemia, and melanoma [113,114,115,116,117,118].